the value of networking in allergy & asthma research judah a. denburg, md, frcp(c)
Post on 04-Feb-2016
20 Views
Preview:
DESCRIPTION
TRANSCRIPT
The Value of Networking in Allergy & Asthma Research
Judah A. Denburg, MD, FRCP(C)Scientific Director and CEO
The Allergy Genes and Environment NetworkGenes & the Environment : The Genesis of
Allergy and Asthma WorkshopMarch 1-3, 2009, Vancouver, BC
Networks of Centres of ExcellenceMission
Mobilize Canada’s research talent
in the academic, private and public
sectors and apply it to developing
the economy and improving the
quality of life of Canadians
Why Canada Built Networks
Vast country
Dispersed institutions
Link strengths
Create critical mass
MicronetMicronet
CANVACCANVAC
AllerGenAllerGenHEALNetHEALNet
SFMSFMPENCEPENCE
Wood-PulpsWood-Pulps
MITACSMITACS
CITRCITR
CBDNCBDN
AquaNetAquaNet
GEOIDEGEOIDECIPICIPI
CGDNCGDN
TL•NCETL•NCE
IRISIRISCSNCSNCANCAN
ISISISIS
Auto21 Auto21 CLLRnetCLLRnetStemNetStemNetCWNCWN
Innovation from cell to society
Federal S&T Strategy
• The Knowledge Advantage
• The People Advantage
• The Entrepreneurial Advantage
Innovation from cell to society
Strategic Positioning of Network Investments
Innovation from cell to society
Innovation from cell to society
Need for AllerGen NCE • Increase in allergic diseases, including asthma,
prevalence: the “Atopic March”
• ~40% of Canadians suffer from allergies
• 1 in 12 Canadians have asthma – chronic
• Allergy and asthma are major policy and public health issues in Canada
• Research and development focused on impact in partnership with industry, healthcare, policy and not-for-profit sectors
Innovation from cell to society
AllerGen’s VISION
To create an enduring network of allergy
and immune disease experts whose
discovery and development efforts contribute
to reductions in the impact of allergic and
related immune diseases nationally and
globally.
Innovation from cell to society
AllerGen’s MISSION
To catalyze and support discovery, development, networking, capacity building, commercialization and knowledge translation that contribute to reducing the morbidity, mortality and socio-economic burden of allergic and related immune diseases.
Networking:Making the connection
• 30 academic institutions
• 28 research institutes
• 200 scientists
• 300 trainees
• 8 global foci
• 7 provinces
Innovation from cell to society
Six Key Accomplishments
• Clinical Investigator Collaborative (CIC)
• Canadian Healthy Infant Longitudinal Development (CHILD) Study
• Genomics and genetics research
• Food allergy research programme
• New training opportunities & partnerships
• International leadership (IPI programme)
Innovation from cell to society
Integrated Programmatic Research Structure
Innovation from cell to society
Integrated Programmatic Research Structure
2007-2012
CHILD CIC
Biomarkers/GeneticsFood Allergy
Mind-Body InteractionsEnvironmental ExposuresPublic Policy, Ethics & Law
Occupational and Work-relatedallergy & asthma
Innovation from cell to society
Networking and Partnerships Progress
• >250 partner organizations• AllerGen leveraging of partner
cash and in-kind contributions exceeds 1:1 target by >100% (2008)
Innovation from cell to society
International Partnership Initiatives
• 5 new international partnerships facilitated by an NCE/IDRC pilot grant 2007-9– GA2LEN (Belgium/EU)– IUALTD (France/ El Salvador/Mexico)– Karolinska Institute (Sweden)– St. John’s Institute (India)– WHO/GARD/ARIA (Montpelier/Geneva)
• New, emerging international collaborations: Europe (GABRIEL), Germany (Humboldt/Helmholtz), Taiwan, China, Israel, USA
Building new relationships industry government academia not-for-profit healthcare
A network of people
“Research is to see what everybody has seen
and to think what nobody has thought."
Albert Szent-Györgyi, 1937 Nobel Prize Winner, Physiology/ Medicine
top related